List was last updated on
.-
- Clinicopathological Features and Outcomes in Individuals with Breast Cancer and ATM, CHEK2, or PALB2 Mutations.
- Bergstrom C, Pence C, Berg J, Partain N, Sadeghi N, Mauer C, Pirzadeh-Miller S, Gao A, Li H, Unni N, Syed S.
- Ann Surg Oncol. 2020 Sep 29. doi: 10.1245/s10434-020-09158-2. Epub ahead of print.
- PMID: 32996020
- PubMed abstract
- Source abstract
-
- Re: Risk-reducing mastectomy: a case series of 124 procedures in Brazilian patients.
- Goncalves R.
- Breast Cancer Res Treat. 2020 Aug;182(3):763-764. doi: 10.1007/s10549-020-05742-y. Epub 2020 Jun 13.
- PMID: 32535766
- PubMed abstract
- Source abstract
Original research:
Risk-reducing mastectomy: a case series of 124 procedures in Brazilian patients.
- PMID: 32215763
- PubMed abstract
- Source abstract
-
- Secondary Angiosarcoma With C-MYC Amplification Following Prophylactic Bilateral Mastectomy and Autologous Breast Reconstruction: Report of a Case and Review of the Literature.
- Webb C, Partain N, Koduru P, Hwang H, Sarode VR.
- Int J Surg Pathol. 2020 Jun 18:1066896920930100. doi: 10.1177/1066896920930100. Epub ahead of print.
- PMID: 32552130
- PubMed abstract
- Source abstract
-
- Increased prevalence of BRCA1/2 mutations in women with macro-textured breast implants and anaplastic large cell lymphoma of the breast.
- De Boer M, Hauptmann M, Hijmering NJ, van Noesel CJM, Rakhorst HA, Meijers-Heijboer HE, Boer JP, van der Hulst RR, De Jong D, van Leeuwen FE.
- Blood. 2020 May 26:blood.2019004498. doi: 10.1182/blood.2019004498. Epub ahead of print.
- PMID: 32452517
- PubMed abstract
- Source abstract
-
- Use of bilateral prophylactic nipple-sparing mastectomy in patients with high risk of breast cancer.
- Valero MG, Moo TA, Muhsen S, Zabor EC, Stempel M, Pusic A, Gemignani ML, Morrow M, Sacchini V.
- Br J Surg. 2020 May 20. doi: 10.1002/bjs.11616. Epub ahead of print.
- PMID: 32432359
- PubMed abstract
- Source abstract
-
- Risk-reducing mastectomy: a case series of 124 procedures in Brazilian patients.
- Frasson AL, Lichtenfels M, de Souza AAB, Vollbrecht B, Falcone AB, Frasson MARM, Barbosa F.
- Breast Cancer Res Treat. 2020 May;181(1):69-75. doi: 10.1007/s10549-020-05582-w. Epub 2020 Mar 25.
- PMID: 32215763
- PubMed abstract
- Source abstract
Letter, Commentary:
Re: Risk-reducing mastectomy: a case series of 124 procedures in Brazilian patients.
- PMID: 32535766
- PubMed abstract
- Source abstract
-
- Increased Overall Mortality Even after Risk Reducing Surgery for BRCA-Positive Women in Western Sweden.
- Öfverholm A, Einbeigi Z, Wigermo A, Holmberg E, Karsson P.
- Genes (Basel). 2019 Dec 16;10(12). pii: E1046. doi: 10.3390/genes10121046.
- PMID: 31888263
- PubMed abstract
- Source abstract
-
- Oncological Safety of Lipofilling in Healthy BRCA Carriers After Bilateral Prophylactic Mastectomy: A Case Series.
- Quoc CH, Dias LPN, Braghiroli OFM, Martella N, Giovinazzo V, Piat JM.
- Eur J Breast Health. 2019 Oct 1;15(4):217-221. doi: 10.5152/ejbh.2019.5013. eCollection 2019 Oct.
- PMID: 31620679
- PubMed abstract
- Source abstract
-
- Risk-reducing mastectomy in BRCA carriers: survival is not the issue.
- Neven P, Punie K, Wildiers H, Willers N, Van Ongeval C, Van Buggenhout G, Legius E.
- Breast Cancer Res Treat. 2019 Sep 20. doi: 10.1007/s10549-019-05440-4. [Epub ahead of print]
- PMID: 31541380
- PubMed abstract
- Source abstract
Letter, Reply:
Risk-reducing mastectomy in BRCA mutation carriers: survival is one of the issues-author's reply.
- PMID: 31691881
- PubMed abstract
- Source abstract
Original Research:
Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers.
- PMID: 31302855
- PubMed abstract
- Free Full Text
-
- Should unaffected female BRCA2 pathogenic variant carriers be told there is little or no advantage from risk reducing mastectomy?
- Evans DG, Howell SJ, Howell A.
- Fam Cancer. 2019 Aug 23. doi: 10.1007/s10689-019-00142-8. [Epub ahead of print]
- PMID: 31444676
- PubMed abstract
- Commentary
- Free Full Text
Original Research:
Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers.
- PMID: 31302855
- PubMed abstract
- Free Full Text
-
- Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers.
- Heemskerk-Gerritsen BAM, Jager A, Koppert LB, Obdeijn AI, Collée M, Meijers-Heijboer HEJ, Jenner DJ, Oldenburg HSA, van Engelen K, de Vries J, van Asperen CJ, Devilee P, Blok MJ, Kets CM, Ausems MGEM, Seynaeve C, Rookus MA, Hooning M.
- Breast Cancer Res Treat. 2019 Jul 13. doi: 10.1007/s10549-019-05345-2. [Epub ahead of print]
- PMID: 31302855
- PubMed abstract
Commentary:
Should unaffected female BRCA2 pathogenic variant carriers be told there is little or no advantage from risk reducing mastectomy?
- PMID: 31444676
- PubMed abstract
- Free Full Text
Letter, Comment:
Risk-reducing mastectomy in BRCA carriers: survival is not the issue.
- PMID: 31541380
- PubMed abstract
- Source abstract
Letter, Reply:
Risk-reducing mastectomy in BRCA mutation carriers: survival is one of the issues-author's reply.
- PMID: 31691881
- PubMed abstract
- Source abstract
-
- Residual glandular tissue (RGT) in BRCA1/2 germline mutation carriers with unilateral and bilateral prophylactic mastectomies.
- Grinstein O, Krug B, Hellmic M, Siedek F, Malter W, Burke C, Schmutzler R, Maintz D, Rhiem K.
- Surg Oncol. 2019 Jun;29:126-133. doi: 10.1016/j.suronc.2019.04.009. Epub 2019 May 3.
- PMID: 31196476
- PubMed abstract
- Source abstract
-
- Sentinel lymph node biopsy following previous axillary surgery in recurrent breast cancer.
- Sávolt Á, Cserni G, Lázár G, Maráz R, Kelemen P, Kovács E, Győrffy B, Udvarhelyi N, Vörös A, Ormándi K, Mátrai Z.
- Eur J Surg Oncol. 2019 May 16. pii: S0748-7983(19)30454-8. doi: 10.1016/j.ejso.2019.05.016. [Epub ahead of print]
- PMID: 31126680
- PubMed abstract
- Source abstract
-
- High rate of occult cancer found in prophylactic mastectomy specimens despite thorough presurgical assessment with MRI and ultrasound: findings from the Hereditary Breast and Ovarian Cancer Registration 2016 in Japan.
- Yamauchi H, Okawa M, Yokoyama S, Nakagawa C, Yoshida R, Suzuki K, Nakamura S, Arai M.
- Breast Cancer Res Treat. 2018 Dec;172(3):679-687. doi: 10.1007/s10549-018-4953-1. Epub 2018 Sep 10.
- PMID: 30203341
- PubMed abstract
-
- Evolving indications and long-term oncological outcomes of risk-reducing bilateral nipple-sparing mastectomy.
- Grobmyer SR, Pederson HJ, Valente SA, Al-Hilli Z, Radford D, Djohan R, Yetman R, Eng C, Crowe JP.
- BJS Open. 2018 Nov 26;3(2):169-173. doi: 10.1002/bjs5.50117. eCollection 2019 Apr.
- PMID: 30957063
- PubMed abstract
- Source abstract
-
- What The Surgeons Should Know About The Bilateral Prophylactic Mastectomy in BRCA Mutation Carriers.
- Franceschini G, Masetti R.
- Eur J Breast Health. 2019 Apr 1;15(2):135-136. doi: 10.5152/ejbh.2019.4651. eCollection 2019 Apr.
- PMID: 31001617
- PubMed abstract
- Source abstract
- Letter, Review
- Free PMC article
- Free Full Text (PDF)
Review:
Risk-Reducing Options for Women with a Hereditary Breast Cancer Predisposition.
- PMID: 30288491
- PubMed abstract
- Source abstract
-
- Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
- Franceschini G, Di Leone A, Terribile D, Sanchez MA, Masetti R.
- Ann Ital Chir. 2019;90:1-2.
- PMID: 30872561
- PubMed abstract
-
- Surgery for BRCA, TP53 and PALB2: a literature review.
- Song CV, Teo SH, Taib NA, Yip CH.
- Ecancermedicalscience. 2018 Aug 29;12:863. doi: 10.3332/ecancer.2018.863. eCollection 2018.
- PMID: 30174725
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
-
- Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.
- Eleje GU, Eke AC, Ezebialu IU, Ikechebelu JI, Ugwu EO, Okonkwo OO.
- Cochrane Database Syst Rev. 2018 Aug 24;8:CD012464. doi: 10.1002/14651858.CD012464.pub2.
- PMID: 30141832
- PubMed abstract
- Source abstract
-
- Uptake of risk-reducing surgery in BRCA gene carriers in Wales, UK.
- Long J, Evans TG, Bailey D, Lewis MH, Gower-Thomas K, Murray A.
- Breast J. 2018 Jul;24(4):580-585. doi: 10.1111/tbj.12978. Epub 2017 Dec 29.
- PMID: 29286205
- PubMed abstract
- Source abstract
-
- Oncological safety of nipple-sparing prophylactic mastectomy: A review of the literature on 3716 cases.
- Muller T, Baratte A, Bruant-Rodier C, Bodin F, Mathelin C.
- Ann Chir Plast Esthet. 2018 Jun;63(3):e6-e13. doi: 10.1016/j.anplas.2017.09.005. Epub 2017 Oct 10.
- PMID: 29030030
- PubMed abstract
- Source abstract
-
- Risk-reducing mastectomy for the prevention of primary breast cancer.
- Carbine NE, Lostumbo L, Wallace J, Ko H.
- Cochrane Database Syst Rev. 2018 Apr 5;4:CD002748. doi: 10.1002/14651858.CD002748.pub4.
- PMID: 29620792
- PubMed abstract
- Source abstract
Summary: Women should be aware of their true risk of developing breast cancer and the limitations of current evidence when considering risk-reducing mastectomy. (Cochrane Library)
-
- Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan.
- Arai M, Yokoyama S, Watanabe C, Yoshida R, Kita M, Okawa M, Sakurai A, Sekine M, Yotsumoto J, Nomura H, Akama Y, Inuzuka M, Nomizu T, Enomoto T, Nakamura S.
- J Hum Genet. 2018 Apr;63(4):447-457. doi: 10.1038/s10038-017-0355-1. Epub 2017 Nov 8.
- PMID: 29176636
- PubMed abstract
-
- Oncologic Safety of Prophylactic Nipple-Sparing Mastectomy in a Population With BRCA Mutations: A Multi-institutional Study.
- Jakub JW, Peled AW, Gray RJ, Greenup RA, Kiluk JV, Sacchini V, McLaughlin SA, Tchou JC, Vierkant RA, Degnim AC, Willey S.
- JAMA Surg. 2018 Feb 1;153(2):123-129. doi: 10.1001/jamasurg.2017.3422.
- PMID: 28903167
- PubMed abstract
- Source abstract
Commentary:
When is a Little Breast Tissue Too Much?: Nipple-Sparing Risk-Reducing Mastectomy in BRCA Carriers.
- PMID: 28903136
- PubMed abstract
- Source abstract
-
- Influence of Risk Category and Screening Round on the Performance of an MR Imaging and Mammography Screening Program in Carriers of the BRCA Mutation and Other Women at Increased Risk.
- Vreemann S, Gubern-Mérida A, Schlooz-Vries MS, Bult P, van Gils CH, Hoogerbrugge N, Karssemeijer N, Mann RM.
- Radiology. 2018 Feb;286(2):443-451. doi: 10.1148/radiol.2017170458. Epub 2017 Oct 16.
- PMID: 29040037
- PubMed abstract
- Source abstract
-
- Risk of breast cancer after a diagnosis of ovarian cancer in BRCA mutation carriers: Is preventive mastectomy warranted?
- McGee J, Giannakeas V, Karlan B, Lubinski J, Gronwald J, Rosen B, McLaughlin J, Risch H, Sun P, Foulkes WD, Neuhausen SL, Kotsopoulos J, Narod SA; Hereditary Ovarian Cancer Clinical Study Group.
- Gynecol Oncol. 2017 May;145(2):346-351. doi: 10.1016/j.ygyno.2017.02.032. Epub 2017 Mar 14.
- PMID: 28314588
- PubMed abstract
- Source abstract
-
- Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review.
- Ludwig KK, Neuner J, Butler A, Geurts JL, Kong AL.
- Am J Surg. 2016 Oct;212(4):660-669. doi: 10.1016/j.amjsurg.2016.06.010. Epub 2016 Jul 18.
- PMID: 27649974
- PubMed abstract
- Source abstract
-
- Effectiveness of Prophylactic Surgeries in BRCA1 or BRCA2 Mutation Carriers: A Meta-analysis and Systematic Review.
- Li X, You R, Wang X, Liu C, Xu Z, Zhou J, Yu B, Xu T, Cai H, Zou Q.
- Clin Cancer Res. 2016 Aug 1;22(15):3971-81. doi: 10.1158/1078-0432.CCR-15-1465. Epub 2016 Mar 15.
- PMID: 26979395
- PubMed abstract
- Meta-Analysis, Review
- Free Full Text (PDF)
-
- Experience with Bilateral Risk-Reducing Mastectomy for an Unaffected BRCA Mutation Carrier.
- Maeshima Y, Oseto K, Katsuragi R, Yoshimoto Y, Takahara S, Yamauchi A.
- J Breast Cancer. 2016 Jun;19(2):218-21. doi: 10.4048/jbc.2016.19.2.218. Epub 2016 Jun 24.
- PMID: 27382401
- PubMed abstract
- Source abstract
- Case report
- Free Full Text
-
- More Proof: Nipple-Sparing Mastectomy Safe for BRCA Carriers.
- Nick Mulcahy.
- Medscape Medical News. Conference News. 17th Annual Meeting of the American Society of Breast Surgeons. 2016 Apr 21.
- Conference report
- Free Full Text
-
- Conservative mastectomies for breast cancer and risk-reducing surgery: the Memorial Sloan Kettering Cancer Center experience.
- Manning AT, Sacchini VS.
- Gland Surg. 2016 Feb;5(1):55-62. doi: 10.3978/j.issn.2227-684X.2015.10.02.
- PMID: 26855909
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
-
- Risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a 30-year semi-prospective analysis.
- Basu NN, Ingham S, Hodson J, Lalloo F, Bulman M, Howell A, Evans DG.
- Fam Cancer. 2015 Dec;14(4):531-8. doi: 10.1007/s10689-015-9825-9.
- PMID: 26239694
- PubMed abstract
- Source abstract
-
- Oncological safety of prophylactic breast surgery: skin-sparing and nipple-sparing versus total mastectomy.
- van Verschuer VM, Maijers MC, van Deurzen CH, Koppert LB.
- Gland Surg. 2015 Dec;4(6):467-75. doi: 10.3978/j.issn.2227-684X.2015.02.01.
- PMID: 26645001
- PubMed abstract
- Source abstract
- Case report, Review
- Free PMC article
- Free Full Text
-
- Nipple-sparing mastectomy in patients with BRCA1/2 mutations and variants of uncertain significance.
- Manning AT, Wood C, Eaton A, Stempel M, Capko D, Pusic A, Morrow M, Sacchini V.
- Br J Surg. 2015 Oct;102(11):1354-9. doi: 10.1002/bjs.9884. Epub 2015 Aug 27.
- PMID: 26313374
- PubMed abstract
- Source abstract
-
- Risk-reducing mastectomy for BRCA gene mutation carriers.
- Euhus DM.
- Ann Surg Oncol. 2015 Sep;22(9):2807-9. doi: 10.1245/s10434-015-4537-9. Epub 2015 Mar 28.
- PMID: 25821000
- PubMed abstract
- Source abstract
-
- Bilateral risk-reduction mastectomy in BRCA1 and BRCA2 mutation carriers: a meta-analysis.
- De Felice F, Marchetti C, Musella A, Palaia I, Perniola G, Musio D, Muzii L, Tombolini V, Benedetti Panici P.
- Ann Surg Oncol. 2015 Sep;22(9):2876-80. doi: 10.1245/s10434-015-4532-1. Epub 2015 Mar 26.
- PMID: 25808098
- PubMed abstract
- Source abstract
-
- Breast cancer after prophylactic mastectomy (bilateral or contralateral prophylactic mastectomy), a clinical entity: presentation, management, and outcomes.
- Mutter RW, Frost MH, Hoskin TL, Johnson JL, Hartmann LC, Boughey JC.
- Breast Cancer Res Treat. 2015 Aug;153(1):183-90. doi: 10.1007/s10549-015-3515-z. Epub 2015 Jul 26.
- PMID: 26210521
- PubMed abstract
- Source abstract
-
- Nipple-sparing mastectomy in BRCA1/2 mutation carriers: an interim analysis and review of the literature.
- Yao K, Liederbach E, Tang R, Lei L, Czechura T, Sisco M, Howard M, Hulick PJ, Weissman S, Winchester DJ, Coopey SB, Smith BL.
- Ann Surg Oncol. 2015 Feb;22(2):370-6. doi: 10.1245/s10434-014-3883-3. Epub 2014 Jul 15.
- PMID: 25023546
- PubMed abstract
- Source abstract
Comment / Editorial
Safely expanding the use of nipple-sparing mastectomy in BRCA mutation carriers.
- PMID: 25201496
- PubMed abstract
- Source abstract
-
- Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation.
- Nelson HD, Pappas M, Zakher B, Mitchell JP, Okinaka-Hu L, Fu R.
- Ann Intern Med. 2014 Feb 18;160(4):255-66.
- PMID: 24366442
- PubMed abstract
- Review
- Free Full Text
Quality-assessed Review: Database of Abstracts of Reviews of Effects (DARE) (PubMed Health)
-
- Assessing the Genetic Risk for BRCA-Related Breast or Ovarian Cancer in Women: Recommendations From the U.S. Preventive Services Task Force.
- [No authors listed]
- Ann Intern Med. 2014 Feb 18;160(4). doi: 10.7326/P14-9008.
- PMID: 24366402
- PubMed abstract
- Summary for Patients
- Free Full Text
Systematic Review:
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation.
- PMID: 24366442
- PubMed abstract
-
- Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: U.S. Preventive Services Task Force Recommendation Statement.
- Moyer VA; U.S. Preventive Services Task Force.
- Ann Intern Med. 2014 Feb 18;160(4):271-81.
- PMID: 24366376
- PubMed abstract
- Practice Guideline
- Free Full Text
Patient Education Handout:
Summaries for patients. Assessing the genetic risk for BRCA-related breast or ovarian cancer in women: recommendations from the U.S. Preventive Services Task Force.
- PMID: 25006622
- PubMed abstract
-
- Summaries for patients. Assessing the genetic risk for BRCA-related breast or ovarian cancer in women: recommendations from the U.S. Preventive Services Task Force.
- [No authors listed]
- Ann Intern Med. 2014 Feb 18;160(4):I-16.
- PMID: 25006622
- PubMed abstract
- Summary for Patients
- Free Full Text
Practice Guideline:
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: U.S. Preventive Services Task Force Recommendation Statement.
- PMID: 24366376
- PubMed abstract
-
- Total skin-sparing mastectomy in BRCA mutation carriers.
- Peled AW, Irwin CS, Hwang ES, Ewing CA, Alvarado M, Esserman LJ.
- Ann Surg Oncol. 2014 Jan;21(1):37-41. doi: 10.1245/s10434-013-3230-0. Epub 2013 Aug 28.
- PMID: 23982256
- PubMed abstract
- Source abstract
-
- Prophylactic mastectomy: an appraisal.
- Zagouri F, Chrysikos DT, Sergentanis TN, Giannakopoulou G, Zografos CG, Papadimitriou CA, Zografos GC.
- Am Surg. 2013 Feb;79(2):205-12.
- PMID: 23336662
- PubMed abstract
- Source abstract